POWER AND STATUS IN JUDGING AND PUNISHING IMMORALITY

This research offers a framework that explains how observers respond to moral violations when considering the amount of power and status held by violators. It follows the group processes literature on the characteristics of power and status. A proposed theory describes that prior to witnessing moral violations, observers develop moral expectations about potential violators on the basis of the levels of power and status attributed to the violators. When the moral violations occur, the moral expectations about the violators, as well as the resources available to the violators, in turn, affect the judgment and punishment decisions of the observers toward the violators. An online vignette study and a laboratory experiment test my predictions based on the proposed theory by varying the relative levels of perceived power and status between evaluation targets (i.e., violators) and evaluators (i.e., observers). Vignettes used in Study 1 described that observers had lower, equal, or higher power/status compared to violators in hypothetical scenarios. In Study 2, observers were assigned with either lower or higher power/status relative to violators in a group interaction setting in which the observers experienced differential risks of retaliation from the violators. Both studies assessed expectations of observers about the moral character of potential violators before exposing the observers to details of a moral violation committed by the designated violators. Punishment decisions of observers examined in Study 1 were attitudinal measures while those in Study 2 were based on behavioral reactions. Results indicate that prior to the immoral incident, observers developed lower moral expectations about violators with greater power and higher moral expectations about violators holding greater status. However, these expectations did not always translate into moral judgment and punishment. While viewing the violation as immoral regardless of power/status held by the violators, depending on the context, observers might or might not penalize the violators differentially across the power/status spectra. Fears of retaliation from violators who utilized resources attached to varied power and status positions did not affect how observers punished the violators. Therefore, results of the studies suggest a resilient power and status hierarchy despite the disruption of moral norms

Toward a Human-Centered AI-assisted Colonoscopy System

AI-assisted colonoscopy has received lots of attention in the last decade. Several randomised clinical trials in the previous two years showed exciting results of the improving detection rate of polyps. However, current commercial AI-assisted colonoscopy systems focus on providing visual assistance for detecting polyps during colonoscopy. There is a lack of understanding of the needs of gastroenterologists and the usability issues of these systems. This paper aims to introduce the recent development and deployment of commercial AI-assisted colonoscopy systems to the HCI community, identify gaps between the expectation of the clinicians and the capabilities of the commercial systems, and highlight some unique challenges in Australia.Comment: 9 page

Biodiesel Produced from Catalyzed Transesterification of Triglycerides Using ion-Exchanged Zeolite Beta and MCM-22

AbstractIn this work, biodiesel production from catalyzed transesterification of triglycerides with excess methanol was studied by using ion-exchanged Zeolite Beta and MCM-22 as heterogeneous catalysts. Zeolite Beta and MCM-22 were synthesized with hydrothermal processes and, subsequently, modified by ion-exchanged with alkali ions. These as-obtained zeolite catalysts could yield a high conversion of triglycerides to biodiesel. The conversion efficiency was largely affected by crystallinity and frameworks of zeolite support, pH value of alkali ion-exchange solutions and alkali loadings onto the zeolite support. Furthermore, the effects of the duration of the sodium ion-exchange process on the final conversion efficiency of triolein to biodiesel, both the as-prepared Zeolite MCM-22 and Zeolite Beta catalysts were used. The effect of the duration of the sodium ion-exchange process is insignificant in transesterification using Na-ion-exchanged Zeolite MCM-22 catalysts from 0.5 to 4h. In contrast, the conversion efficiency of triolein to biodiesel reached ca. 95% in 0.5hours of transesterification using Zeolite Beta ion-exchanged with 3 mmol-eq. Na+/g cat for 0.5hours

The Different Clinical Features Between Autoimmune and Infectious Status Epilepticus

Objective: The prognosis of status epilepticus (SE) is highly related to the underlying etiology. Inflammation of the central nervous system (CNS), including infection and autoimmune encephalitis, is one of the treatable conditions causing SE. The initial presentation of infectious and autoimmune CNS disorders can be quite similar, which may be difficult to differentiate at the beginning. However, treatment for these entities can be quite different. In this study, we aim to identify the differences in clinical features among patients with infectious and autoimmune SE, which could help the clinicians to select initial investigation and ensuing therapies that may improve overall outcomes.Methods: This was a retrospective study that included 501 patients with SE within a period of 10.5-years. Patients with inflammatory etiology were collected and separated into infectious and autoimmune SE. The symptoms at onset, SE semiology, status epilepticus severity score, and END-IT score at admission, treatment for SE, and outcome (modified Rankin Scale) on discharge and last follow-up were recorded. Data on the first cerebrospinal fluid, electroencephalography, and magnetic resonance imaging were also collected.Results: Forty-six (9.2%) of the 501 patients had SE with inflammatory etiology. Twenty-five (5%) patients were autoimmune SE and 21 (4.2%) were infectious SE. Patients with autoimmune SE have younger age and female predominance. As for clinical presentations, psychosis, non-convulsive SE, and super refractory SE were more common in patients with autoimmune SE. Nevertheless, the prognosis showed no difference between the two groups.Conclusion: The different initial clinical presentations and patient characteristics may provide some clues about the underlying etiology of SE. When inflammatory etiology is suspected in patients with SE, younger age, female sex, psychosis, non-convulsive SE, and super refractory SE are clinical features that suggest an autoimmune etiology

Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma

Abstract Background The nomogram of the Barcelona Clinic Liver Cancer (BCLC) for hepatocellular carcinoma (HCC) has been used for outcome prediction. Patients with BCLC stage C HCC often undergo anti-cancer therapy against current treatment guidelines in real world practice. We aimed to use the nomogram to provide guidance on treatment selection for BCLC stage C patients. Methods A total of 1317 patients with stage C HCC were retrospectively analyzed and divided into four groups by nomogram points. One-to-one matched pairs between patients receiving different treatments were generated by the propensity score with matching model within these groups. Survival analysis was performed by Kaplan-Meier method with log-rank test. Results Patients with higher nomogram points were more often treated with targeted or supportive therapies (p  15, there was no significant difference in survival between patients receiving two different treatment strategies. Conclusions The nomogram of BCLC system is a feasible tool to help stage C HCC patients to select primary anti-cancer treatment in pursuance of better overall survival.https://deepblue.lib.umich.edu/bitstream/2027.42/142787/1/12885_2018_Article_4202.pd

Albuminâ bilirubin gradeâ based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma

Background & AimsThe prognostic accuracy of individual hepatocellular carcinoma (HCC) patient in each Barcelona Clinic Liver Cancer (BCLC) stage is unclear. We aimed to develop and validate an albuminâ bilirubin (ALBI) gradeâ based nomogram of BCLC to estimate survival for individual HCC patient.MethodsBetween 2002 and 2016, 3690 patients with newly diagnosed HCC were prospectively enrolled and retrospectively analysed. Patients were randomly split into derivation and validation cohort by 1:1 ratio. Multivariate Cox proportional hazards model was used to generate the nomogram from tumour burden, ALBI grade and performance status (PS). The concordance index and calibration plot were determined to evaluate the performance of this nomogram.ResultsBeta coefficients from the Cox model were used to assign nomogram points to different degrees of tumour burden, ALBI grade and PS. The scores of the nomogram ranged from 0 to 24, and were used to predict 3â and 5â year patient survival. The concordance index of this nomogram was 0.77 (95% confidence interval [CI]: 0.71â 0.81) in the derivation cohort and 0.76 (95% CI: 0.71â 0.81) in the validation cohort. The calibration plots to predict both 3â and 5â year survival rate well matched with the 45â degree ideal line for both cohorts, except for ALBIâ based BCLC stage 0 in the validation cohort.ConclusionsThe proposed ALBIâ based nomogram of BCLC system is a simple and feasible strategy in the precision medicine era. Our data indicate it is a straightforward and userâ friendly prognostic tool to estimate the survival of individual HCC patient except for very early stage patients.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/153250/1/liv14249_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/153250/2/liv14249.pd